Modular Medical, Inc. Common Stock

MODD

Modular Medical, Inc. (MODD) is a medical device company focused on developing and commercializing innovative solutions for the management of diabetes. The company's flagship product is a wearable insulin management system designed to improve the quality of life for individuals with diabetes by providing precise, automated insulin delivery. Modular Medical aims to simplify diabetes care through advanced automation and user-friendly design.

$2.98 -0.26 (-7.97%)
🚫 Modular Medical, Inc. Common Stock does not pay dividends

Company News

AI-IoT Chipset Industry Insights and Forecast 2025-2035 - Expanding Applications Across Various Sectors Coupled With Strategic Startup Funding and Continuous Technological Advancements Drive Opportunities
GlobeNewswire Inc. • Researchandmarkets.Com • April 2, 2025

The AI-IoT chipset market is expected to grow rapidly, driven by advancements in AI-driven data analytics, digital twins, and blockchain integration. The market is segmented by end-use applications and technologies, with opportunities across consumer electronics, automotive, healthcare, and industrial sectors.

Modular Medical (MODD) Pairing Technology Issued New U.S. Patent
Zacks Investment Research • Zacks Equity Research • February 5, 2024

Modular Medical's (MODD) latest U.S. patent is likely to protect the company's technology addressing pairing and allow clinicians to easily upload and review patients' data.

Modular Medical, Inc. (MODD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks Investment Research • Zacks Equity Research • February 2, 2024

Modular Medical, Inc. (MODD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Lisa Levin • October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 53.1% to $0.3264 after the comp...

Modular Medical And 2 Other Stocks Under $2 Insiders Are Buying
Benzinga • Lisa Levin • October 19, 2023

The Dow Jones closed lower by over 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider tra...

Related Companies